A minimum of two years of undertreated primary hypothyroidism, as a result of drug-induced malabsorption of l-thyroxine, may have metabolic and cardiovascular consequences

Highlights•L-T4 malabsorption is frequently encountered in clinical practice. •Drug induced L-T4 malabsorption has metabolic and cardiovascular consequences. •Control of TSH is not enough when drug induced L-T4 malabsorption is suspected.

Saved in:

Bibliographic Details
Published in:	Journal of clinical & translational endocrinology Vol. 16; p. 100189
Main Authors:	Benvenga, Salvatore, Pantano, Rachele, Saraceno, Giovanna, Lipari, Luigi, Alibrando, Antonio, Inferrera, Santi, Pantano, Giuseppe, Simone, Giuseppe, Tamà, Sebastiano, Scoglio, Riccardo, Ursino, Maria Giovanna, Simone, Carmen, Catalano, Antonino, Alecci, Umberto
Format:	Journal Article
Language:	English
Published:	Netherlands Elsevier Inc 01-06-2019 Elsevier
Subjects:	Cardiovascular diseases Diabetes mellitus Dyslipidemia Endocrinology and Metabolism Hypertension Levothyroxine malabsorption Research Paper Subclinical hypothyroidism Hypertension Levothyroxine malabsorption Cardiovascular diseases Subclinical hypothyroidism Diabetes mellitus Dyslipidemia
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Highlights•L-T4 malabsorption is frequently encountered in clinical practice. •Drug induced L-T4 malabsorption has metabolic and cardiovascular consequences. •Control of TSH is not enough when drug induced L-T4 malabsorption is suspected.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	2214-6237 2214-6237
DOI:	10.1016/j.jcte.2019.100189